Skip to main content
. 2019 Apr 8;76(7):764–773. doi: 10.1001/jamaneurol.2019.0617

Table 2. Rate of Ischemic Stroke and Association of Rivaroxaban vs Aspirin by Tertiles of HAVOC Score, Frequency of Premature Atrial Contractions, and Left Atrial Diameter.

Subgroup AF Reported, No. (%) Rivaroxaban Group (n = 3563) Aspirin Group (n = 3549) Rivaroxaban vs Aspirin
Randomized, No. No. of Events (Events Ratea) Randomized, No. No. of Events (Events Ratea) Hazard Ratio (95% CI)b P Value for Interactionb P Value for Trend
Overallc 239 (3.4) 3563 158 (4.8) 3549 153 (4.6) 1.03 (0.83-1.29) .78 NA
HAVOC score
0-4 199 (3.1) 3218 141 (4.7) 3158 129 (4.4) 1.07 (0.84-1.36) .68 .41
5-9 40 (5.6) 332 16 (5.4) 376 22 (6.1) 0.86 (0.45-1.64)
10-14 0 (0.0) 13 1 (7.0) 15 2 (17.0) 0.23 (0.02-2.92)
HAVOC score
Tertile 1: 0-2 96 (2.3) 2103 98 (5.1) 2027 87 (4.7) 1.08 (0.81-1.45) .67 .45
Tertile 2: 3 34 (3.0) 553 18 (3.4) 562 15 (2.9) 1.20 (0.61-2.39)
Tertile 3: >3 109 (5.8) 907 42 (5.0) 960 51 (5.5) 0.89 (0.59-1.35)
Atrial premature beats per 24 hd
Tertile 1: 0-20 10 (1.3) 365 22 (6.8) 404 17 (4.5) 1.47 (0.78-2.77) .96 .77
Tertile 2: 21-123 22 (2.9) 384 21 (5.8) 368 14 (4.2) 1.40 (0.71-2.76)
Tertile 3: >123 52 (7.0) 347 22 (6.7) 401 20 (5.1) 1.31 (0.72-2.41)
Atrial premature beats per 24 hd
≤720 60 (3.1) 964 56 (6.3) 1003 40 (4.3) 1.47 (0.98-2.20) .53 NA
>720 24 (7.9) 132 9 (7.4) 170 11 (6.7) 1.07 (0.45-2.59)
Longest episode of SVT, mind
Tertile 1: 0-1 1 (1.7) 33 0 (0.0) 27 0 (0.0) NA NA NA
Tertile 2: 2-5 2 (10.5) 12 0 (0.0) 7 0 (0.0) NA NA NA
Tertile 3: >5 2 (5.9) 12 0 (0.0) 22 3 (14.4) NA NA NA
No. of episodes of SVT per 24 hd
Tertile 1: 0-2 9 (2.1) 196 12 (6.9) 225 6 (3.0) 2.32 (0.87-6.20) .23 .19
Tertile 2: 3-10 11 (4.1) 140 6 (4.3) 131 7 (6.4) 0.66 (0.22-1.98)
Tertile 3: >10 16 (4.9) 162 8 (4.7) 165 8 (5.2) 0.96 (0.36-2.56)
LA diameter, cm
Tertile 1: 0-3.4 24 (1.8) 683 43 (7.0) 680 22 (3.5) 1.97 (1.18-3.29) .02 .03
Tertile 2: 3.5-4 50 (3.4) 725 26 (3.9) 758 38 (5.2) 0.74 (0.45-1.21)
Tertile 3: >4 58 (4.9) 587 25 (4.5) 589 28 (5.0) 0.90 (0.52-1.54)
LA diameter, cm
≤4.6 109 (3.0) 1808 91 (5.5) 1853 77 (4.4) 1.23 (0.91-1.67) .02 NA
>4.6 23 (6.4) 187 3 (1.7) 174 11 (6.5) 0.26 (0.07-0.94)
Combined atrial myopathy risk factorse
No risk factor 166 (2.9) 2921 131 (4.9) 2883 121 (4.6) 1.07 (0.83-1.37) .54 NA
≥1 Risk factors 73 (5.6) 642 27 (4.4) 666 32 (4.9) 0.89 (0.53-1.48)
Age, y
Tertile 1: 0-62 32 (1.3) 1190 50 (4.7) 1186 41 (3.7) 1.24 (0.82-1.87) .52 .25
Tertile 2: 63-71 78 (3.3) 1214 52 (4.6) 1178 48 (4.5) 1.03 (0.70-1.53)
Tertile 3: >71 129 (5.5) 1159 56 (5.1) 1185 64 (5.7) 0.90 (0.63-1.29)
AF5F scoref
Tertile 1: 0-56.88 38 (1.5) 1256 52 (4.6) 1233 41 (3.6) 1.27 (0.84-1.91) .47 .23
Tertile 2: 56.89-63.72 81 (3.4) 1190 51 (4.6) 1173 50 (4.6) 0.99 (0.67-1.46)
Tertile 3: >63.72 120 (5.3) 1117 55 (5.2) 1143 62 (5.8) 0.90 (0.63-1.30)

Abbreviations: AF, atrial fibrillation; LA, left atrial; NA, not applicable; SVT, supraventricular tachycardia.

a

Event rates reported in 100 person-years.

b

Hazard ratio, 95% CI, and P for interaction not reported if hazard ratio is ≥10 or cannot be computed.

c

Randomized participants in NAVIGATE ESUS without AF/flutter reported at baseline.

d

Information available only if Holter electrocardiogram performed as a measure for cardiac rhythm monitoring.

e

One point: HAVOC score, >7; 1 point: >720 premature atrial contractions per 24 hours; 1 point: LA diameter, >41 mm.

f

AF5F score: (age at baseline × 0.76) + 9 (+ 12 points, if baseline National Institutes of Health Stroke Scale score >5).